The company has also signed a similar agreement with Russian company JSC World to introduce its products in that market.
"The two new agreements, in addition to the agreement in China announced recently, are part of a strategic decision in Syneron to enter these three emerging markets for medical aesthetic products in their early stage of development", Moshe Mizrahy, CEO of the Nasdaq-listed company, said in the release.